Senseonics Holdings, Inc. (SENS) Financial Analysis & Valuation | Quarter Chart
Senseonics Holdings, Inc. (SENS)
SENSPrice: $5.64
Fair Value: 🔒
🔒score
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable C... more
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous gluc... more
Description
Shares
| Market Cap | $235.59M | Exchange | AMEX |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Timothy T. Goodnow |
| IPO Date | 2015-12-22 | CAGR | 0.89% |
| Employees | 117 | Website | www.senseonics.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
SENS chart loading...
Fundamentals
Technicals
| Enterprise Value | $187.71M | P/E Ratio | -3.4 |
| Forward P/E | -2.54 | PEG Ratio | — |
| P/S Ratio | 2.88 | P/B Ratio | 1.7 |
| P/CF Ratio | -1.62 | P/FCF Ratio | -1.56 |
| EPS | $-1.66 | EPS Growth 1Y | -33.97% |
| EPS Growth 3Y | -57.19% | EPS Growth 5Y | -89.3% |
| Revenue Growth 1Y | 56.89% | Gross Margin | 0.45% |
| Operating Margin | -1.94% | Profit Margin | -1.96% |
| ROE | -1.03% | ROA | -0.55% |
| ROCE | -0.67% | Current Ratio | 4.83 |
| Quick Ratio | 4.55 | Cash Ratio | 1.65 |
| Debt/Equity | 0.67 | Interest Coverage | -5.42 |
| Altman Z Score | -9.09 | Piotroski Score | 4 |